ReviewClinical and experimental medicine2025

Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems.

Ahmed Aljabri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.